Results 111 to 120 of about 135,907 (335)

CONJUNCTIVAL AMYLOIDOSIS [PDF]

, 1959
S. P. Mathur, B. P. Mathur
openalex   +1 more source

Cardiac amyloidosis

Swiss Medical Weekly
Cardiac amyloidosis is a disease characterised by the accumulation of amyloid protein in the heart tissue. There are several types of amyloidosis, but the most common types affecting the heart are ATTR amyloidosis (caused by transthyretin protein) and AL amyloidosis (caused by abnormal immunoglobulin light chains).
Natallia Laptseva, Dominik C. Benz, Rahel Schwotzer, Andreas J. Flammer   +3 more
openaire   +3 more sources

Prognostic utility of advanced lung cancer inflammation index in heart failure with preserved ejection fraction

ESC Heart Failure, EarlyView.
The advanced lung cancer inflammation index (ALI) is an integrated marker of inflammation and nutritional status, calculated by body mass index × serum albumin / neutrophil‐to‐lymphocyte ratio. Low ALI levels were significantly associated with poor prognosis in elderly multimorbid HFpEF patients.
Daisuke Sakamoto, Yuki Matsuoka, Masahiro Seo, Takahisa Yamada, Daisaku Nakatani, Katsuki Okada, Akihiro Sunaga, Hirota Kida, Taiki Sato, Tetsuhisa Kitamura, Shunsuke Tamaki, Masamichi Yano, Takaharu Hayashi, Akito Nakagawa, Yusuke Nakagawa, Yoshio Yasumura, Shungo Hikoso, Yohei Sotomi, Yasushi Sakata, on behalf of the OCVC‐Heart Failure Investigators   +19 more
wiley   +1 more source

Primary Amyloidosis: A Review [PDF]

, 1956
W. St. C. Symmers
openalex   +1 more source

Classification of amyloidosis

Baillière's Clinical Rheumatology, 1994
Amyloidosis is a collective term for a heterogeneous group of disorders characterized by deposition of a fibrillar, proteinaceous material, amyloid, in various tissues and organs. Increasing knowledge about the different proteins that constitute the amyloid fibrils has made it possible to classify amyloidosis by the fibril protein, which appears more ...
openaire   +4 more sources

[Lysozyme amyloidosis].

La Revue de medecine interne, 2019
L’amylose à lysozyme est une amylose héréditaire non neuropathique identifiée en 1993. Elle reste une pathologie rare avec une cinquantaine de cas rapportés, et probablement encore sous-diagnostiquée.L’amylose à lysozyme présente un très large spectre de manifestations cliniques.
M, Scafi, S, Valleix, A, Benyamine, E, Jean, J-R, Harlé, P, Rossi, L, Daniel, N, Schleinitz, B, Granel   +8 more
openaire   +2 more sources

Identification, characterisation and outcomes of pre‐atrial fibrillation in heart failure with reduced ejection fraction

ESC Heart Failure, EarlyView.
Abstract Aims Atrial fibrillation (AF) in heart failure with reduced ejection fraction (HFrEF) has prognostic implications. Using a machine learning algorithm (FIND‐AF), we aimed to explore clinical events and the cardiac magnetic resonance (CMR) characteristics of the pre‐AF phenotype in HFrEF.
Anna Helbitz, Ramesh Nadarajah, Lan Mu, Harriet Larvin, Hesham Ismail, Ali Wahab, Patrick Thompson, Peter Harrison, Mohammad Harris, Tobin Joseph, Sven Plein, Mark Petrie, Marco Metra, Jianhua Wu, Peter Swoboda, Chris P. Gale   +15 more
wiley   +1 more source

Amyloidosis in Still's Disease [PDF]

, 1951
John James, F. G. Bolton
openalex   +1 more source

Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy

ESC Heart Failure, EarlyView.
Results and clinical implication of repeat endomyocardial biopsy (EMB). Abstract Aims While the diagnostic role of endomyocardial biopsy (EMB) in myocarditis is unquestioned, little is known about its indications and clinical value during long‐term follow‐up.
Anna Baritussio, Andrea Silvio Giordani, Stefania Rizzo, Cristina Vicenzetto, Monica De Gaspari, Elisa Carturan, Giuseppe Toscano, Federico Scognamiglio, Giuseppe Tarantini, Sabino Iliceto, Cristina Basso, Renzo Marcolongo, Alida Linda Patrizia Caforio   +12 more
wiley   +1 more source

Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period

Blood Cancer Journal
The treatment landscape of multiple myeloma (MM) has evolved significantly over four decades, driven by novel therapies and optimized supportive care. However, the attrition rate (AR), defined as the proportion of patients who die without advancing to ...
Luis Gerardo Rodríguez-Lobato, Anna de Daniel, Arturo Pereira, Carlos Fernández de Larrea, Natalia Tovar, M. Teresa Cibeira, David F. Moreno, Jose Miguel Mateos, Noemí Llobet, Esther Carcelero, Daniel Munárriz, Joan Bladé, Laura Rosiñol   +12 more
doaj   +1 more source